NCT03284593View on ClinicalTrials.gov

Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition

Active, not recruitingOBSERVATIONAL

Enrollment

199

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

intensive chemotherapy

DRUG

Azacitidine

Trial Locations (2)

31052

University Hospital Toulouse, Toulouse

Unknown

University Hospital Bordeaux, Bordeaux

All Listed Sponsors

lead

University Hospital, Toulouse

OTHER

NCT03284593 - Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition | Biotech Hunter | Biotech Hunter